World Health Organization (WHO) and serum tumor marker (CA125) response with platinum based chemotherapy after treatment with paclitaxel in patients with advanced ovarian cancer (ADOVCA)

J.B Vermorken; R.V.H.P. Huijskes; K. Hoekman; RHM Verheijen; C.W. Burger; M.A. Heitbrink; H.M. Pinedo

World Health Organization (WHO) and serum tumor marker (CA125) response with platinum based chemotherapy after treatment with paclitaxel in patients with advanced ovarian cancer (ADOVCA)

J.B Vermorken
, R.V.H.P. Huijskes
, K. Hoekman
, RHM Verheijen
, C.W. Burger
, M.A. Heitbrink
, H.M. Pinedo

Research output: Contribution to conference › Abstract › Other research output

Original language	English
Publication status	Published - 1995
Event	ECCO - , United Kingdom Duration: 15 May 1995 → …

Conference

Conference	ECCO
Country/Territory	United Kingdom
Period	15/05/95 → …

Cite this

@conference{2ce28a328859430288be89ce3b76d0a0,

title = "World Health Organization (WHO) and serum tumor marker (CA125) response with platinum based chemotherapy after treatment with paclitaxel in patients with advanced ovarian cancer (ADOVCA)",

author = "J.B Vermorken and R.V.H.P. Huijskes and K. Hoekman and RHM Verheijen and C.W. Burger and M.A. Heitbrink and H.M. Pinedo",

year = "1995",

language = "English",

note = "ECCO ; Conference date: 15-05-1995",

}

TY - CONF

T1 - World Health Organization (WHO) and serum tumor marker (CA125) response with platinum based chemotherapy after treatment with paclitaxel in patients with advanced ovarian cancer (ADOVCA)

AU - Vermorken, J.B

AU - Huijskes, R.V.H.P.

AU - Hoekman, K.

AU - Verheijen, RHM

AU - Burger, C.W.

AU - Heitbrink, M.A.

AU - Pinedo, H.M.

PY - 1995

Y1 - 1995

M3 - Abstract

T2 - ECCO

Y2 - 15 May 1995

ER -